Total cohort (N = 3,222) | N (%) | |
---|---|---|
Age, years | <16 | 243 (7.6Â %) |
16–34 | 1482 (46.4 %) | |
35–50 | 831 (26 %) | |
50+ | 635 (19.9) | |
Gender male | Male | 1466 (57.5Â %) |
Female | 1078 (42.3Â %) | |
Ethnicity code | White | 616 (23.0Â %) |
Black African/Caribbean | 977 (36.5Â %) | |
Asian | 641 (23.9Â %) | |
Eastern Mediterranean and North Africa | 297 (11.1Â %) | |
Americas | 148 (5.5Â %) | |
Site of disease | Pulmonary or mediastinal lymph node | 1780 (55.2Â %) |
Pleural or pericardial | 233 (7.2Â %) | |
Abdominal | 119 (3.7Â %) | |
Miliary/disseminated | 75 (2.3Â %) | |
Bone and joint | 197 (6.1Â %) | |
Peripheral lymph node | 533 (16.5Â %) | |
Skin and soft tissue | 31 (1.0Â %) | |
CNS | 126 (3.9Â %) | |
Other/unknown | 128 (4.0Â %) | |
Culture status | Culture negative | 1027 (32.5Â %) |
Culture positive | 2136 (67.5Â %) | |
Smear status (pulmonary cases) | Smear negative | 598 (54.7Â %) |
Smear positive | 495 (45.3Â %) | |
HIV Status | HIV positive | 333 (10.3Â %) |
HIV negative | 2020 (62.8Â %) | |
HIV status unknown | 865 (26.9Â %) |